Literature DB >> 10908220

Cardioprotective mechanism of ischemic preconditioning is impaired by postinfarct ventricular remodeling through angiotensin II type 1 receptor activation.

T Miki1, T Miura, A Tsuchida, A Nakano, T Hasegawa, T Fukuma, K Shimamoto.   

Abstract

BACKGROUND: Activation of protein kinase C-linked receptors and subsequent opening of the mitochondrial ATP-sensitive K(+) (mitoK(ATP)) channel are crucial in preconditioning (PC). This study examined whether postinfarct ventricular remodeling interferes with the PC mechanism. METHODS AND
RESULTS: Two weeks before isolation of hearts, rabbits underwent a sham operation or coronary ligation (COL) to induce remodeling. Isolated buffer-perfused hearts were subjected to 30-minute global ischemia/2-hour reperfusion, and infarct size was expressed as a percentage of the left ventricle (%I/LV), from which the scarred infarct by COL was excluded. Although %I/LV was similar in sham-operated and remodeled hearts (52.9+/-6.5% versus 45.8+/-5.2%), PC with 2 episodes of 5-minute ischemia protected sham-operated but not remodeled hearts (%I/LV=18.1+/-2.5% versus 54.8+/-2.9%, P<0.05). Infusion of valsartan (10 mg x kg(-1). d(-1), an angiotensin II type 1 (AT(1)) receptor blocker, for 2 weeks after COL prevented the ventricular remodeling and preserved the response to PC (%I/LV=27.4+/-3.8%), although valsartan alone did not change %I/LV. Diazoxide, a mitoK(ATP) channel opener, protected both sham-operated and remodeled hearts (%I/LV=14.1+/-3.1% and 8.3+/-3.6%).
CONCLUSIONS: The myocardium remodeled after infarction is refractory to PC, which is probably due to interruption of cellular signaling by PC upstream of mitoK(ATP) channels. An AT(1) receptor blocker is beneficial not only for suppression of ventricular remodeling but also for preservation of the PC mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908220     DOI: 10.1161/01.cir.102.4.458

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  10 in total

1.  Ischaemic preconditioning effect of prodromal angina pectoris is lost in patients with prior myocardial infarction.

Authors:  M Ishihara; I Inoue; T Kawagoe; Y Shimatani; S Kurisu; T Hata; Y Nakama; Y Kijima; E Kagawa
Journal:  Heart       Date:  2006-07       Impact factor: 5.994

Review 2.  Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.

Authors:  Karin Przyklenk
Journal:  Drugs Aging       Date:  2011-05-01       Impact factor: 3.923

Review 3.  Role of Erythropoiesis-Stimulating Agents in Cardiovascular Protection in CKD Patients: Reappraisal of Their Impact and Mechanisms.

Authors:  Tetsuji Miura; Tatsuya Sato; Toshiyuki Yano; Akira Takaguri; Takayuki Miki; Noritsugu Tohse; Keitaro Nishizawa
Journal:  Cardiovasc Drugs Ther       Date:  2022-02-12       Impact factor: 3.727

4.  Interruption of signal transduction between G protein and PKC-epsilon underlies the impaired myocardial response to ischemic preconditioning in postinfarct remodeled hearts.

Authors:  Takayuki Miki; Tetsuji Miura; Masaya Tanno; Jun Sakamoto; Atsushi Kuno; Satoshi Genda; Tomoaki Matsumoto; Yoshihiko Ichikawa; Kazuaki Shimamoto
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

5.  Preischemic infusion of alpha-human atrial natriuretic peptide elicits myoprotective effects against ischemia reperfusion in isolated rat hearts.

Authors:  Hirohisa Okawa; Hitoshi Horimoto; Shigetoshi Mieno; Yukiya Nomura; Masataka Yoshida; Sasaki Shinjiro
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

6.  Repetitive preischemic infusion of phosphodiesterase III inhibitor olprinone elicits cardioprotective effects in the failing heart after myocardial infarction.

Authors:  Yukiya Nomura; Hitoshi Horimoto; Shigetoshi Mieno; Ken-ichi Nakahara; Hirohisa Okawa; Masataka Yoshida; Sasaki Shinjiro
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

7.  Does enhanced expression of the Na+-Ca2+ exchanger increase myocardial vulnerability to ischemia/reperfusion injury in rabbit hearts?

Authors:  Tomoaki Matsumoto; Tetsuji Miura; Takayuki Miki; Yasuhiro Nishino; Yuichi Nakamura; Kazuaki Shimamoto
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

Review 8.  Protection of the abnormal heart.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

9.  Inhibitory effects of edaravone on the production of tumor necrosis factor-alpha in the isolated heart undergoing ischemia and reperfusion.

Authors:  Shunji Onimaru; Kazuo Nakamura; Hiroko Kariyazono; Ryuji Ikeda; Takayuki Ueno; Yoshihiro Fukumoto; Akira Yabuki; Ryuzo Sakata; Katsushi Yamada
Journal:  Heart Vessels       Date:  2006-03       Impact factor: 2.037

Review 10.  Myocardial protection in man--from research concept to clinical practice.

Authors:  Dennis V Cokkinos; Costas Pantos
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.